Advisory Committee to the Director, Centers for Disease Control and Prevention-Health Disparities Subcommittee, 1379 [2014-00043]
Download as PDF
<![CDATA[
Federal Register / Vol. 79, No. 5 / Wednesday, January 8, 2014 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Centers for Disease Control and
Prevention
Advisory Committee to the Director,
Centers for Disease Control and
Prevention—Health Disparities
Subcommittee
Advisory Board on Radiation and
Worker Health, National Institute for
Occupational Safety and Health
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following meeting of the
aforementioned subcommittee:
mstockstill on DSK4VPTVN1PROD with NOTICES
Time and Date: 10:00 a.m.–12:00 p.m.
EDT, February 13, 2014.
Place: Teleconference.
Status: This meeting is open to the public,
limited only by the availability of telephone
ports. The public is welcome to participate
during the public comment period, which is
tentatively scheduled from 11:45 a.m. to
11:55 a.m. To participate on the
teleconference, please dial (866) 763–0273
and enter code 6158968.
Purpose: The Subcommittee will provide
advice to the CDC Director through the
Advisory Committee to the Director (ACD) on
strategic and other health disparities and
health equity issues and provide guidance on
opportunities for CDC.
Matters To Be Discussed: The Health
Disparities Subcommittee (HSD) members
will discuss some of the current health equity
activities at CDC, as well as discuss health
equity recommendations to the CDC ACD.
The agenda is subject to change as
priorities dictate.
Contact Person for More Information:
Leandris Liburd, Ph.D., M.P.H., M.A.,
Designated Federal Officer, Health
Disparities Subcommittee, ACD, CDC, 1600
Clifton Road NE., M/S K–77, Atlanta, Georgia
30333, Telephone (770) 488–8182, Email:
LEL1@cdc.gov.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Gary J. Johnson,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 2014–00043 Filed 1–7–14; 8:45 am]
BILLING CODE 4163–18–P
VerDate Mar<15>2010
16:42 Jan 07, 2014
Jkt 232001
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), and pursuant to the
requirements of 42 CFR 83.15(a), the
Centers for Disease Control and
Prevention (CDC), announces the
following meeting of the Advisory
Board on Radiation and Worker Health
(ABRWH or Advisory Board), National
Institute for Occupational Safety and
Health (NIOSH):
Time and Date: (All times are Central
Standard Time) 9 a.m.–5:30 p.m., January 28,
2014.
Public Comment Time and Date: (All times
are Central Standard Time) 5:30 p.m.–6:30
p.m., January 28, 2014.
*Please note that the public comment
period may end before the time indicated,
following the last call for comments.
Members of the public who wish to provide
public comments should plan to attend the
public comment session at the start time
listed.
Place: Crowne Plaza, 1301 Wyandotte,
Kansas City, MO, 64105 Phone: 816–460–
6664; Fax: 816–474–0424. Audio Conference
Call via FTS Conferencing. The USA toll-free,
dial-in number is 1–866–659–0537 with a
pass code of 9933701. Live Meeting
Connection: https://www.livemeeting.com/
cc/cdc/join?id=JKQMG2&role=
attend&pw=ABRWH; Meeting ID: JKQMG2;
Entry Code: ABRWH
Status: Open to the public, limited only by
the space available. The meeting space
accommodates approximately 150 people.
Background: The Advisory Board was
established under the Energy Employees
Occupational Illness Compensation Program
Act of 2000 to advise the President on a
variety of policy and technical functions
required to implement and effectively
manage the new compensation program. Key
functions of the Advisory Board include
providing advice on the development of
probability of causation guidelines which
have been promulgated by the Department of
Health and Human Services (HHS) as a final
rule, advice on methods of dose
reconstruction which have also been
promulgated by HHS as a final rule, advice
on the scientific validity and quality of dose
estimation and reconstruction efforts being
performed for purposes of the compensation
program, and advice on petitions to add
classes of workers to the Special Exposure
Cohort (SEC).
In December 2000, the President delegated
responsibility for funding, staffing, and
operating the Advisory Board to HHS, which
subsequently delegated this authority to the
CDC. NIOSH implements this responsibility
for CDC. The charter was issued on August
PO 00000
Frm 00018
Fmt 4703
Sfmt 4703
1379
3, 2001, renewed at appropriate intervals,
and will expire on August 3, 2015.
Purpose: This Advisory Board is charged
with a) providing advice to the Secretary,
HHS, on the development of guidelines
under Executive Order 13179; b) providing
advice to the Secretary, HHS, on the
scientific validity and quality of dose
reconstruction efforts performed for this
program; and c) upon request by the
Secretary, HHS, advise the Secretary on
whether there is a class of employees at any
Department of Energy facility who were
exposed to radiation but for whom it is not
feasible to estimate their radiation dose, and
on whether there is reasonable likelihood
that such radiation doses may have
endangered the health of members of this
class.
Matters To Be Discussed: The agenda for
the Advisory Board meeting includes: NIOSH
Program Update; Department of Labor
Program Update; Department of Energy
Program Update; SEC petitions for: Joslyn
Manufacturing and Supply Company (Fort
Wayne, IN) and Kansas City Plant (Kansas
City, MO); SEC Issues Work Group Report on
‘‘Sufficient Accuracy’’/Co-Worker Dose
Modeling; SEC Petitions Update, and Board
Work Sessions.
The agenda is subject to change as
priorities dictate.
In the event an individual cannot attend,
written comments may be submitted in
accordance with the redaction policy
provided below. Any written comments
received will be provided at the meeting and
should be submitted to the contact person
below well in advance of the meeting.
Policy on Redaction of Board Meeting
Transcripts (Public Comment): (1) If a person
making a comment gives his or her personal
information, no attempt will be made to
redact the name; however, NIOSH will redact
other personally identifiable information,
such as contact information, social security
numbers, case numbers, etc., of the
commenter.
(2) If an individual in making a statement
reveals personal information (e.g., medical or
employment information) about themselves
that information will not usually be redacted.
The NIOSH Freedom of Information Act
(FOIA) coordinator will, however, review
such revelations in accordance with the
Federal Advisory Committee Act and if
deemed appropriate, will redact such
information.
(3) If a commenter reveals personal
information concerning a living third party,
that information will be reviewed by the
NIOSH FOIA coordinator, and upon
determination, if deemed appropriate, such
information will be redacted, unless the
disclosure is made by the third party’s
authorized representative under the Energy
Employees Occupational Illness
Compensation Program Act (EEOICPA)
program.
(4) In general, information concerning a
deceased third party may be disclosed;
however, such information will be redacted
if (a) the disclosure is made by an individual
other than the survivor claimant, a parent,
spouse, or child, or the authorized
representative of the deceased third party; (b)
E:\FR\FM\08JAN1.SGM
08JAN1
]]>Agencies
[Federal Register Volume 79, Number 5 (Wednesday, January 8, 2014)]
[Notices]
[Page 1379]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-00043]
[[Page 1379]]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Advisory Committee to the Director, Centers for Disease Control
and Prevention--Health Disparities Subcommittee
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the following meeting of the aforementioned
subcommittee:
Time and Date: 10:00 a.m.-12:00 p.m. EDT, February 13, 2014.
Place: Teleconference.
Status: This meeting is open to the public, limited only by the
availability of telephone ports. The public is welcome to
participate during the public comment period, which is tentatively
scheduled from 11:45 a.m. to 11:55 a.m. To participate on the
teleconference, please dial (866) 763-0273 and enter code 6158968.
Purpose: The Subcommittee will provide advice to the CDC
Director through the Advisory Committee to the Director (ACD) on
strategic and other health disparities and health equity issues and
provide guidance on opportunities for CDC.
Matters To Be Discussed: The Health Disparities Subcommittee
(HSD) members will discuss some of the current health equity
activities at CDC, as well as discuss health equity recommendations
to the CDC ACD.
The agenda is subject to change as priorities dictate.
Contact Person for More Information: Leandris Liburd, Ph.D.,
M.P.H., M.A., Designated Federal Officer, Health Disparities
Subcommittee, ACD, CDC, 1600 Clifton Road NE., M/S K-77, Atlanta,
Georgia 30333, Telephone (770) 488-8182, Email: LEL1@cdc.gov.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention
and the Agency for Toxic Substances and Disease Registry.
Gary J. Johnson,
Acting Director, Management Analysis and Services Office, Centers for
Disease Control and Prevention.
[FR Doc. 2014-00043 Filed 1-7-14; 8:45 am]
BILLING CODE 4163-18-P
